Active

S. DERVEAUX PHARMA - CONSULTING

Switched

BE0466336012

Rechtspersoon Besloten Vennootschap 1 establishment

Active for

26 year, 10 months

Registered office

Kerkdreef 20

2310 Rijkevorsel

België

Names & denominations

S. DERVEAUX PHARMA - CONSULTING

Official name

NL

S.D.P.

Commercial name

NL

Enterprise details

Enterprise type

Rechtspersoon

Legal form

Besloten Vennootschap

Legal situation

Normale toestand

Start date

24 June 1999

Contact

Not specified

Peppol

Active
0208:0466336012

Active since 28 Aug 2025

Powered by

Databakkes.be

Company info. No nonsense.

Activities

NACE-BEL activity descriptions are currently shown in Dutch. English translations are underway.

NACE-BEL activities

What does this company officially do?

82990 Main activity

Overige zakelijke dienstverlening, neg

74879 Main activity

Overige zakelijke dienstverlening, n.e.g.

What are NACE codes? NACE-BEL is the Belgian version of the European activity nomenclature. Each company has at least one code indicating its main activity.

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkdreef 20

2310 Rijkevorsel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Frequently asked questions

What is the enterprise number of S. DERVEAUX PHARMA - CONSULTING?
The enterprise number of S. DERVEAUX PHARMA - CONSULTING is BE0466336012.
What is the address of S. DERVEAUX PHARMA - CONSULTING?
The registered office of S. DERVEAUX PHARMA - CONSULTING is located at Kerkdreef 20, 2310 Rijkevorsel.
When was S. DERVEAUX PHARMA - CONSULTING founded?
S. DERVEAUX PHARMA - CONSULTING was founded on 24 June 1999.
What is the main activity of S. DERVEAUX PHARMA - CONSULTING?
The main activity of S. DERVEAUX PHARMA - CONSULTING is "Overige zakelijke dienstverlening, neg" (NACE code 82990).
Does S. DERVEAUX PHARMA - CONSULTING have a website?
No website is currently known for S. DERVEAUX PHARMA - CONSULTING.